Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Kim

Showing results (441-450 of 446) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 446 results.
Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022Margaret von Mehren, John M Kane, Richard F Riedel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, John M Kane, Mark Agulnik, et al.
Nature Communications|January 6, 2018
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitorsJay H Kalin, Muzhou Wu, Andrea V Gomez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025Margaret von Mehren, John M Kane, Samantha A Armstrong, et al.
The Lancet. Gastroenterology & Hepatology|January 22, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trialThomas U Marron, Maria Isabel Fiel, Pauline Hamon, et al.
Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.
Pageof 45

Showing results (441-450 of 446) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 446 results.
Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022Margaret von Mehren, John M Kane, Richard F Riedel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, John M Kane, Mark Agulnik, et al.
Nature Communications|January 6, 2018
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitorsJay H Kalin, Muzhou Wu, Andrea V Gomez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025Margaret von Mehren, John M Kane, Samantha A Armstrong, et al.
The Lancet. Gastroenterology & Hepatology|January 22, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trialThomas U Marron, Maria Isabel Fiel, Pauline Hamon, et al.
Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.
Pageof 45